COVID-19 community-based treatments

Please note this information is for clinicians only. If you have a patient enquiry regarding access to COVID treatments please contact your GP or call NHS 111. Further information for patients is available on the nhs.uk website.

Clinical Commissioning Policies

Title Date published/updated
Interim Clinical Commissioning Policy: Remdesivir and molnupiravir for non-hospitalised patients with COVID-19 11 May 2023
Commissioning Framework: COVID-19 therapeutics for non-hospitalised patients 22 December 2022
Interim Clinical Commissioning Policy: Treatments for non-hospitalised patients with COVID-19 28 November 2022

Information for clinicians and NHS managers

Title Date published/updated
Transition of COVID treatments to routine pathways 27 March 2023
Role of 111 teams in supporting patient access to treatments for COVID-19 28 February 2023
Fact sheet – Role of general practice teams in supporting patient access to COVID-19 treatments 9 January 2023
Cohorts eligible for community COVID-19 treatments who require contact by consultants 8 June 2022
Letter to clinicians: Contacting your patients about new COVID-19 treatments 8 June 2022
Letter to General Practices : Deployment of COVID-19 treatments for highest risk non-hospitalised patients 31 May 2022
Treatments for non-hospitalised patients at highest risk from COVID-19 infection aged 12 years and over: Update to supporting information for NHS111/IUC CAS service providers 9 February 2022
Assessment, monitoring and management of symptomatic COVID-19 patients in the community 6 January 2022
COVID Medicine Delivery Unit directory 3 February 2022

Patient facing information for clinicians

Title Date published/updated
Paxlovid antiviral medicine patient leaflet 4 May 2022
Molnupiravir patient information leaflet 4 May 2022
Letter to patients: Important information about new treatments for coronavirus 31 March 2022